Introducing BioVision's Liquid Biopsy Kits

MILPITAS, Calif. - Oct. 19, 2018 - PRLog -- BioVision offers Liquid Biopsy DNA and RNA kits to selectively purify tumor-originated nucleic acids from tumor enriched extracellular vesicles (EVs) and exosomes in biofluids. The purification is based on proprietary peptide affinity method and does not require any special equipment, such as ultracentrifugation or chromatography. The Liquid Biopsy kits yield the highest level of enrichment of tumor genetic material. It doesn't require the time-consuming ultracentrifugation steps. Additionally, users can choose from different biofluids including serum, plasma, input volumes and DNA/RNA specific workflows.


Applications:
• EV-associated RNA isolation using RNA kit
• Cell free circulating and EV-associated DNA using DNA kit
• DNA or RNA purification


Key Features:
• Ready-To-Use Reagents
• User-friendly protocol
• Unique: To selectively purify tumor- originated nucleic acids from tumor enriched EVs and exosomes from biofluids
• Fast and Accurate: No time-consuming ultracentrifugation step needed
• Turnaround time is a minimum of 3-4 hours
• Versatile: Users can choose from different biofluids and input volumes

Below are our products with catalog number and size:
LiqBiopsy Tumor Exosome RNA Kit (K1254, 24 Reactions)
LiqBiopsy Tumor Exosome DNA Kit I (K1255, 20 Reactions)
LiqBiopsy Tumor Exosome DNA Kit II (K1256, 20 Reactions)

For detailed information on these products, visit: https://www.biovision.com/products/exosome-research/liqui...

www.BioVision.com